TLR8 agonists stimulate newly recruited monocyte-derived cells into potent APCs that enhance HBsAg immunogenicity

Vaccine

Volumn 28, Issue 38, 2010, Pages 6273-6281

  Du, Jun ^a   Wu, Zhiyuan ^a   Ren, Shurong ^a,b   Wei, Yong ^a   Gao, Meihua ^b   Randolph, Gwendalyn J ^c   Qu, Chunfeng ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cellular immune responses; Monocyte derived dendritic cells; TLR8 agonists

Indexed keywords

CL 075; CL 097; GAMMA INTERFERON; GARDIQUIMOD; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G2A; INTERLEUKIN 5; RESIQUIMOD; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG POTENTIATION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MONOCYTE; PRIORITY JOURNAL; SPLEEN CELL;

ALUM COMPOUNDS; AMINOQUINOLINES; ANIMALS; ANTIBODIES, VIRAL; ANTIGEN-PRESENTING CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMIDAZOLES; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-5; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED C57BL; QUINOLINES; SPLEEN; THIAZOLES; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 8;

EID: 77955656853     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.06.117     Document Type: Article

References (35)

1. Kool M., Soullie T., van Nimwegen M., Willart M.A., Muskens F., Jung S., et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med 2008, 205(April 14 (4)):869-882.
2. Steinman R.M. Dendritic cells in vivo: a key target for a new vaccine science. Immunity 2008, 29(September 19 (3)):319-324.
3. Leon B., Lopez-Bravo M., Ardavin C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 2007, 26(April (4)):519-531.
4. Le Borgne M., Etchart N., Goubier A., Lira S.A., Sirard J.C., van Rooijen N., et al. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 2006, 24(February (2)):191-201.
5. van Duin D., Medzhitov R., Shaw A.C. Triggering TLR signaling in vaccination. Trends Immunol 2006, 27(January (1)):49-55.
6. Leon B., Ardavin C. Monocyte-derived dendritic cells in innate and adaptive immunity. Immunol Cell Biol 2008, 86(May-June (4)):320-324.
7. Sun Z., Zhu Y., Stjernsward J., Hilleman M., Collins R., Zhen Y., et al. Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study. Cancer Detect Prev 1991, 15:313-318.
8. Sun Z., Ming L., Zhu X., Lu J. Prevention and control of hepatitis B in China. J Med Virol 2002, 67(July (3)):447-450.
9. Yang P.L., Althage A., Chung J., Maier H., Wieland S., Isogawa M., et al. Immune effectors required for hepatitis B virus clearance. Proc Natl Acad Sci U S A 2010, 107(January 12 (2)):798-802.
10. Chisari F.V., Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995, 13:29-60.
11. Qu C., Nguyen V., Merad M., Randolph G. MHC class I/peptide transfer between dendritic cells overcomes poor cross-presentation by monocyte-derived APCs that engulf dying cells. J Immunol 2009, 182(March 15 (6)):3650-3659.
12. Wille-Reece U., Flynn B.J., Lore K., Koup R.A., Kedl R.M., Mattapallil J.J., et al. HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates. Proc Natl Acad Sci U S A 2005, 102(October 18 (42)):15190-15194.
13. Wille-Reece U., Flynn B.J., Lore K., Koup R.A., Miles A.P., Saul A., et al. Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates. J Exp Med 2006, 203(May 15 (5)):1249-1258.
14. Weeratna R.D., Makinen S.R., McCluskie M.J., Davis H.L. TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848). Vaccine 2005, 23(November 1 (45)):5263-5270.
15. Jarrossay D., Napolitani G., Colonna M., Sallusto F., Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 2001, 31(November (11)):3388-3393.
16. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001, 194(September 17 (6)):863-869.
17. Krug A., Towarowski A., Britsch S., Rothenfusser S., Hornung V., Bals R., et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol 2001, 31(October (10)):3026-3037.
18. Ito T., Amakawa R., Kaisho T., Hemmi H., Tajima K., Uehira K., et al. Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med 2002, 195(June 3 (11)):1507-1512.
19. Larange A., Antonios D., Pallardy M., Kerdine-Romer S. TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation. J Leukoc Biol 2009, 85(April (4)):673-683.
20. Jurk M., Heil F., Vollmer J., Schetter C., Krieg A.M., Wagner H., et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 2002, 3(June (6)):499.
21. Randolph G.J., Beaulieu S., Lebecque S., Steinman R.M., Muller W.A. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998, 282(October 16 (5388)):480-483.
22. Qu C., Moran T.M., Randolph G.J. Autocrine type I IFN and contact with endothelium promote the presentation of influenza A virus by monocyte-derived APC. J Immunol 2003, 170(January 15 (2)):1010-1018.
23. Randolph G.J., Furie M.B. Mononuclear phagocytes egress from an in vitro model of the vascular wall by migrating across endothelium in the basal to apical direction: role of intercellular adhesion molecule 1 and the CD11/CD18 integrins. J Exp Med 1996, 183(2):451-462.
24. Amemiya K., Meyers J.L., Rogers T.E., Fast R.L., Bassett A.D., Worsham P.L., et al. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague. Vaccine 2009, 27(April 6 (16)):2220-2229.
25. Karlmark K.R., Weiskirchen R., Zimmermann H.W., Gassler N., Ginhoux F., Weber C., et al. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 2009, 50(July (1)):261-274.
26. Sallusto F., Lanzavecchia A. The instructive role of dendritic cells on T-cell responses. Arthritis Res 2002, 4(Suppl 3):S127-S132.
27. Sallusto F., Reiner S.L. Sliding doors in the immune response. Nat Immunol 2005, 6(January (1)):10-12.
28. Seubert A., Monaci E., Pizza M., O'Hagan D.T., Wack A. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. J Immunol 2008, 180(April 15 (8)):5402-5412.
29. Ma Y., Poisson L., Sanchez-Schmitz G., Pawar S., Qu C., Randolph G.J., et al. Assessing the immunopotency of Toll-like receptor agonists in an in vitro tissue-engineered immunological model. Immunology 2010, (Mar 17).
30. Qu C., Edwards E.W., Tacke F., Angeli V., Llodra J., Sanchez-Schmitz G., et al. Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J Exp Med 2004, 200(November 15 (10)):1231-1241.
31. Seder R.A., Darrah P.A., Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 2008, 8(April (4)):247-258.
32. Jakubzick C., Bogunovic M., Bonito A.J., Kuan E.L., Merad M., Randolph G.J. Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes. J Exp Med 2008, 205(November 24 (12)):2839-2850.
33. Gorden K.B., Gorski K.S., Gibson S.J., Kedl R.M., Kieper W.C., Qiu X., et al. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol 2005, 174(February 1 (3)):1259-1268.
34. Schmitt N., Morita R., Bourdery L., Bentebibel S.E., Zurawski S.M., Banchereau J., et al. Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity 2009, 31(July 17 (1)):158-169.
35. Mullen G.E., Aebig J.A., Dobrescu G., Rausch K., Lambert L., Long C.A., et al. Enhanced antibody production in mice to the malaria antigen AMA1 by CPG 7909 requires physical association of CpG and antigen. Vaccine 2007, 25(July 20 (29)):5343-5347.